Q3 2005 Report: 20% sales growth, positive result

Two Acquisitions in the Biomaterials Segment

aap Implantate AG completes capital increase

Terms of Capital Increase, Guarantee of existing shareholders

Management Board changes, CEO Uwe Ahrens to move to Supervisory Board

New bone cement contract, changes on the Board, capital increase

Q2 2005 Report: Sales up 16%, marked improvement in result

Report for the First Quarter of 2005: Total sales slightly up on year, sales growth of 18% in Germany, operating result EUR 6,000, equity ratio 76%

Termination of supply agreement for Palacos

Consolidated Annual Financial Statement 2004 of aap Implantate AG: Company’s restructuring concluded, sales growth of 5%, result almost in balance and equity ratio increased to 76%

aap Implantate AG signs long-term production services agreement

aap Implantate AG publishes interim sales figures for the fourth quarter and full financial year 2004